XML 83 R68.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Revenue - Additional Information (Detail) - Licensing Agreement [Member] - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2021 | Jun. 30, 2021
Oasmia [Member] |  |
Statement [line items] |  |
Upfront payment received |  | $ 4,000
Simcere Pharmaceutical Group Limited [Member] |  |
Statement [line items] |  |
Upfront payment received | $ 11,000 |
Upfront payment received in cash | 7,000 |
Upfront payment received in shares | $ 4,000 |
Premium on investment percentage | 20.00% |
Oasmia And Simcere Pharmaceutical Group [Member] |  |
Statement [line items] |  |
Revenue recognized out of consideration received from customers during the period |  | 0
Oasmia Pharmceutical AB And Sincere Pharmaceuticals Group Limited [Member] |  |
Statement [line items] |  |
Revenue from performance obligations satisfied or partially satisfied in previous periods |  | 11,000
Commercial Milestone [Member] | Oasmia [Member] |  |
Statement [line items] |  |
Contingent milestone payment receivable |  | 42,000
Commercial Milestone [Member] | Simcere Pharmaceutical Group Limited [Member] |  |
Statement [line items] |  |
Contingent milestone payment receivable |  | $ 281,000

X
- Definition The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2021-01-01 -Paragraph 116 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_c&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contingent milestone payment receivable. + References No definition available. + Details
Name: | kzia_ContingentMilestonePaymentReceivable
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Premium on investment percentage. + References No definition available. + Details
Name: | kzia_PremiumOnInvestmentPercentage
Namespace Prefix: | kzia_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue recognized out of consideration received from customers during the period. + References No definition available. + Details
Name: | kzia_RevenueRecognizedOutOfConsiderationReceivedFromCustomersDuringThePeriod
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | kzia_StatementLineItems
Namespace Prefix: | kzia_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront payment received. + References No definition available. + Details
Name: | kzia_UpfrontPaymentReceived
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payment received in cash. + References No definition available. + Details
Name: | kzia_UpfrontPaymentReceivedInCash
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payment received in shares. + References No definition available. + Details
Name: | kzia_UpfrontPaymentReceivedInShares
Namespace Prefix: | kzia_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=kzia_OasmiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | kzia_AgreementAxis=kzia_LicensingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=kzia_SimcerePharmaceuticalGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=kzia_OasmiaAndSimcerePharmaceuticalGroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=kzia_OasmiaPharmceuticalAbAndSincerePharmaceuticalsGroupLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | kzia_MilestoneAxis=kzia_CommercialMilestoneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |